Evolan Pharma AB is a Swedish AB based in Danderyd, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2006, the company has 30 employees and reported revenue of SEK 1.2bn in its latest annual filing.
In its most recent annual report (2025), Evolan Pharma AB reported revenue of SEK 1.2bn, an increase of 18% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of SEK 527.0m, and the EBITDA margin stood at 47.8%.
At the end of 2025, equity financed 84.1% of the balance sheet, and current assets covered short-term debt 5.8 times.
Frequently asked questions
What is the Org number of Evolan Pharma AB?
Evolan Pharma AB is registered with Bolagsverket / SCB under Org 5567189781.
What is the revenue of Evolan Pharma AB?
Evolan Pharma AB reported revenue of SEK 1.2bn in 2025.
How many employees does Evolan Pharma AB have?
Evolan Pharma AB employs 30 people as of the latest annual report.
Who is the CEO of Evolan Pharma AB?
Said Richard Karroum is the CEO of Evolan Pharma AB, in role since 2021.
Who is the chairman of Evolan Pharma AB?
Said Richard Karroum chairs the board of Evolan Pharma AB, in role since 2024.
Where is Evolan Pharma AB headquartered?
Evolan Pharma AB's registered address is Svärdvägen 19.
